Chiron and XOMA Form Collaboration For Development and Commercialization Of Therapeutic Antibodies For Cancer
Agreement Leverages Companies' Strengths in Oncology, Antibody Discovery and Product Development
02-Mar-2004 -
EMERYVILLE, Calif., and BERKELEY, Calif. Chiron Corporation and XOMA Ltd. announced a worldwide, exclusive, multi-product, collaborative agreement for the development and commercialization of antibody products for the treatment of cancer. Under the terms of the agreement, the companies will ...
antibodies
biopharmaceuticals
Chiron
+9